Daily Report Card 6 March 2024

March 6, 2024

DENVER, Colo., Mar 06, 2024 (247marketnews.com) –

Aptorum Group Limited (NASDAQ:APM), Brera Holdings (NASDAQ:BREA), TRxADE HEALTH Inc. (NASDAQ:MEDS), BiomX Inc. (NYSE:PHGE), and Airship AI Holdings, Inc. (NASDAQ:AISP) are some of the listings we featured this morning.

Aptorum Group Limited (NASDAQ:APM) announced, jointly with privately-held YOOV Group Holding Ltd., this morning, that the two companies entered into an Agreement and Plan of Merger, which still needs shareholder approval, which we covered when APM was trading at $2.7399, up $1.0699 (+64.07%), on 5,809,021 shares, after it traded as high as $6.29 in this morning’s premarket.

Its 52-week range was $1.35 to $9.00, before it hit $17.49 in today’s trading. It closed today’s session at $9.49, up $8.0399 (+554.44%), on 82.3M shares.

“We are pleased to announce our proposed reverse merger with YOOV Group Holding, which we believe will be in the best interest of our shareholders,” said Ian Huen, Executive Director and Chief Executive Officer of Aptorum Group. “YOOV is a promising AI-enabled software and automation platform. The merger is an exciting and important transaction that will take YOOV to listing on Nasdaq, which I believe will open further opportunities for the company to drive growth towards new heights.”

Brera Holdings (NASDAQ:BREA) stated, this morning, that the Company added Massimo Ferragamo, Chairman of Ferragamo USA, to its newly formed top-tier Advisory Board, as the world’s first publicly-traded multi-club ownership (“MCO”) company in global football (American soccer).

BREA opened at $0.92 and closed today at $1.02, up $0.08 (+8.51%), 45K shares.

Ferragamo joins Alan Rothenberg, Major League Soccer Founder and World Cup Director, Sports Business Leaders, Paul Tosetti and Marshall Geller, and Football Icon, Giuseppe Rossi.

“In addition to leading one of the most famous global luxury fashion houses, with his family, Massimo Ferragamo’s name is synonymous with elevated lifestyle, so his valued perspective is the perfect addition to our all-star Advisory Board. We were diligent in working to ensure that Brera’s Advisory Board will provide visionary leadership, as we continue to drive our MCO strategy forward,” stated Christopher Paul Gardner, Brera’s Director and Compensation Committee Chairman.

In addition to leading Ferragamo USA, since 2000, after serving as that company’s President since 1985, Ferragamo is also Vice President of the Lungarno Hotel Group and Executive Vice President of the Ferragamo Foundation. Other current and former directorships and associations include: director of Ferragamo Finanziaria S.p.A.; Board of Directors member for Yum! Brands, Inc.; multiple Philip Morris International, Inc. Board Committees; Board Member of The American-Italian Cancer Foundation; Board of Directors member for Birks Group, Inc; and Board of Directors member for Mayor’s Jewelers, Inc.

“We are truly blessed to strengthen an already amazing Advisory Board and are pleased to welcome Massimo, Alan, Paul, Marshall, and Giuseppe to Brera’s Advisory Board at this exciting time. Each member will bring their diverse expertise, unique background, and professional experience. I am looking forward to receiving their valuable counsel and honored that they chose to join the Brera team,” said Pierre Galoppi, Brera’s Chief Executive Officer.

Ferragamo was instrumental in introducing Giuseppe Rossi, former Florentine football icon, to also become a member of the Brera Advisory Board. Rossi and the other board members’ biographies are as follows;

Alan Rothenberg could rightly be referred to as the “father of football (soccer)” in the United States, and is the namesake of the Alan I. Rothenberg Trophy, which was awarded annually to the winner of the MLS Cup from 1996 to 2007. Rothenberg was president of U.S. Soccer, the governing body of American soccer during the 1990s and oversaw both the 1994 FIFA World Cup in the United States and the establishment of Major League Soccer  (“MLS”) in 1996.  He was chairman of the 1999 Women’s World Cup and instrumental in the awarding of the 2026 FIFA World Cup to the U.S., Canada, and Mexico.  Rothenberg is a recipient of the FIFA Order of Merit.  In addition to his achievements in soccer, he was responsible for moving the NBA’s San Diego Clippers to Los Angeles, founded Premier Partnerships as a leading sports sponsorship agency with Randy Bernstein before selling it to Playfly Sports, and founded and serves as chairman of Los Angeles-based 1st Century Bank.

Paul Tosetti is described by American Chambers as a “legend” and a “phenomenal lawyer” for his extensive experience representing clients in complex M&A transactions, hostile takeovers, and private equity. He was a partner in the Los Angeles office of Latham & Watkins and Co-Chair of the firm’s Global Mergers & Acquisitions Practice where he worked for Alan Rothenberg in connection with the 1994 World Cup, and where one of his notable former colleagues was Ivan Gazidis, who went on to become CEO of Arsenal F.C. and AC Milan.  Tosetti represented Allergan, Inc. in its response to the US$53 billion attempted hostile takeover effort by Valeant Pharmaceuticals (and the associated proxy contest led by Pershing Square and Bill Ackman) and the subsequent sale of Allergan to Actavis plc in a US$73 billion transaction.

Giuseppe Rossi is an American-born soccer star with Italian immigrant parents whose career started at Manchester United where he debuted at 17 years old and scored in his Premiership debut. He later transferred to Spain’s Villarreal FC and became the highest goal scorer in club history after five years with the team scoring 82 goals in 192 games. Rossi went on to play for Fiorentina in Italy’s Serie A for three years and is considered a legend at the club. He finished his career with 143 goals in 397 games played.  Rossi also played for the Italian national team, where he was the top scorer in the 2008 Summer Olympics.  He retired in 2023 and founded and operates the Giuseppe Rossi Academy and soccer camp in New Jersey, in addition to other businesses.

Marshall Geller is a former Senior Managing Director for Bear, Stearns & Company, with oversight of all operations in Los Angeles, San Francisco, Chicago, Hong Kong and the Far East. He founded private equity fund St. Cloud Capital and is an active investor in growth companies through SCF Investments.  Geller was the owner of the trailblazing San Francisco women’s professional basketball team The Pioneers in 1979, long before the WNBA. He also owned an interest in the Chicago Bulls with Jerry Reinsdorf.  Never shy about taking calculated risks, Geller presciently hired then-homeless Chris Gardner at Dean Witter Reynolds, who became a successful stockbroker, building his own firm before Will Smith earned an Academy Award nomination for portraying him in the film The Pursuit of Happyness, which grossed nearly half a billion dollar worldwide.  Geller has been a member of the board of directors for numerous Nasdaq and New York Stock Exchange listed companies.

“Landing an all-star team to join our Advisory Board is a resounding stamp of approval for Brera’s business model. By leveraging public markets, we’re able to quickly scale and build long-term shareholder value as the world’s first Nasdaq-listed MCO global brand. Further, with our board’s diverse expertise in professional sports we are able to utilize their counsel as we identify, negotiate and close significant material acquisitions,” said Mr. Gardner, Brera’s Director and Compensation Committee Chairman.

TRxADE HEALTH Inc. (NASDAQ:MEDS) announced, this morning, that its board of directors declared a special cash dividend of $8.00 per share of common stock, which is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company’s web-based market platform assets and is payable to stockholders of record as of March 18, 2024, with the dividend being paid on or about March 22, 2024.

MEDS was trading at $11.52, up $3.1901 (+38.30%), on 1.8M shares, when we covered it.

Its 52-week range was $3.69 to $19.7001. It hit a new 52-week high of $21.2199 and closed today at $17.26, up $8.9301 (+107.21%), on 9.2M shares.

TRxADE Health’s about section states “is a parent company with various subsidiaries which include the pharmaceutical marketplace https://rx.trxade.com, plant-based food www.superlatus.com.”

BiomX Inc. (NYSE:PHGE) stated, this morning, that it agreed to merge with Adaptive Phage Therapeutics, Inc. (“APT”), a privately-held, clinical-stage biotechnology company that’s based in the U.S. and is pioneering the development of phage-based therapies to combat bacterial infections.

PHGE was trading at $0.48, up $0.2489 (+107.70%), on 7.1M shares when we covered.

Its 52-week range was $0.1866 to $0.65, but it, too, hit a new 52-week high of $0.855 and closed trading at $0.6879, up $0.4568 (+197.66%), on 139.9M shares.

BiomX will own approximately 55% of the merged companies and the former stockholders of APT will own approximately 45% of the consolidated entity of BiomX and APT, and the acquisition is expected to close within the next 30 days.

BiomX also entered into a placement for the sale of shares of newly created non-voting convertible preferred stock and warrants that is expected to result in gross proceeds to BiomX of $50 million before deducting placement agent and other offering expenses.

“BiomX’s acquisition of APT will create a leading phage company with diverse technologies and an advanced clinical pipeline,” said Jonathan Leff, Partner and Chairman of the Deerfield Institute at Deerfield Management. “With important data readouts for two programs expected in 2025, the funding from this transaction is designed to provide multiple opportunities to create stockholder value by reaching critical inflection points in each program’s clinical development.”

Airship AI Holdings, Inc. (NASDAQ:AISP) stated, yesterday morning, that it was awarded a large contract to an agency within the Department of Justice (DOJ) for the Company’s Acropolis Enterprise Sensor Management video and data management platform supporting emerging public safety and investigative requirements.

AISP was trading at $3.0115, up $1.3615 (+82.52%), on 81M shares when we covered.

Its 52-week range is $1.34 to $13.355, but fell short in today’s attempt at breaing its 52-week high. After hitting $9.3158, it closed trading at $6.92, up $1.97 (+39.80%), on 67.4M shares.

“This award represents an expansion of a pilot program started with the agency in 2023, validating our ability to meet demanding agency operational and security requirements,” said Paul Allen, President of Airship AI. “Equally as exciting is this project represents the second U.S. Government agency to deploy our Acropolis platform in a FedRAMP certified cloud environment, a government-wide program that provides a standardized approach to security assessment, authorization, and continuous monitoring for cloud products and services.”

Allen concluded, “Reflected in our strong pipeline for 2024, Airship AI is actively working to drive digital transformation for video and sensor data from the edge to the cloud across the U.S. Government and with governments around the world, by empowering front-line operators and data consumers to leverage the latest in AI and sensor management capabilities.”

For 24/7 Market News BREA disclosure go here

Connect with 24/7 Market News @
247marketnews.com
X (formerly twitter)
Facebook

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.

24/7 MARKET NEWS, INC Disclaimer
24/7 Market News (24/7MN) is a third-party publisher and online news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ, and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7 MN is not affiliated with any company written about in this release and owns no shares of stock. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. Few succeed in the stock market. Don’t trade if you’re not able to devote the necessary time. Earmark your surplus funds that you’re prepared to lose. Assess your risk appetite and set your stops accordingly, and honor your stop losses. Always employ loss limiting strategies. Be prepared to be blindsided by hidden risks, a bad company financing or other move can turn gains into losses. Learn technical analysis, charting, patterns, and setups. Buying at the bottom and selling at the top is a myth. The middle half of a move is the sweet spot and learn how to exit a winning position, because trying to time the exact top can turn into big losses. Trade small and take advantage of small price move strategies, like scalping. Remove emotional and psychological biases, and consider that you’re competing against professionals who’re deploying a number of powerful stock market tools. Successful traders make more on their winners than they lose on their losers. Learn how to interpret the ECN/Level 2 data. The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.
Please go to 247marketnews.com or https://247marketnews.com/disclaimer/ for further information.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (APM, BREA, MEDS, PHGE, AISP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.